Utah Medical Products Stock Price Prediction
| UTMD Stock | USD 65.25 0.10 0.15% |
Oversold Vs Overbought
53
Oversold | Overbought |
Quarterly Earnings Growth (0.05) | Quarterly Revenue Growth (0.20) |
Using Utah Medical hype-based prediction, you can estimate the value of Utah Medical Products from the perspective of Utah Medical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Utah Medical to buy its stock at a price that has no basis in reality. In that case, they are not buying Utah because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Utah Medical after-hype prediction price | USD 65.22 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Utah |
Utah Medical After-Hype Price Prediction Density Analysis
As far as predicting the price of Utah Medical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Utah Medical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Utah Medical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Utah Medical Estimiated After-Hype Price Volatility
In the context of predicting Utah Medical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Utah Medical's historical news coverage. Utah Medical's after-hype downside and upside margins for the prediction period are 64.14 and 66.30, respectively. We have considered Utah Medical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Utah Medical is very steady at this time. Analysis and calculation of next after-hype price of Utah Medical Products is based on 3 months time horizon.
Utah Medical Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Utah Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Utah Medical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Utah Medical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.02 | 1.08 | 0.03 | 0.02 | 10 Events / Month | 10 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
65.25 | 65.22 | 0.05 |
|
Utah Medical Hype Timeline
Utah Medical Products is at this time traded for 65.25. The entity has historical hype elasticity of -0.03, and average elasticity to hype of competition of -0.02. Utah is expected to decline in value after the next headline, with the price expected to drop to 65.22. The average volatility of media hype impact on the company price is about 83.72%. The price decrease on the next news is expected to be -0.05%, whereas the daily expected return is at this time at -0.02%. The volatility of related hype on Utah Medical is about 87.04%, with the expected price after the next announcement by competition of 65.23. About 74.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 1.78. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Utah Medical Products last dividend was issued on the 16th of December 2024. The entity had 3:2 split on the 22nd of March 1993. Given the investment horizon of 90 days the next expected press release will be in about 10 days. Check out Utah Medical Basic Forecasting Models to cross-verify your projections.Utah Medical Related Hype Analysis
Having access to credible news sources related to Utah Medical's direct competition is more important than ever and may enhance your ability to predict Utah Medical's future price movements. Getting to know how Utah Medical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Utah Medical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| POCI | Precision Optics, | (0.36) | 7 per month | 0.00 | (0.04) | 7.48 | (6.99) | 18.59 | |
| KRMD | Repro Med Systems | 0.23 | 9 per month | 2.30 | 0.19 | 6.37 | (4.40) | 18.56 | |
| INFU | InfuSystems Holdings | 1.15 | 12 per month | 2.72 | 0.10 | 6.79 | (4.81) | 22.10 | |
| MLSS | Milestone Scientific | 0.01 | 9 per month | 3.61 | 0.01 | 9.68 | (7.89) | 27.59 | |
| PDEX | Pro Dex | 1.05 | 8 per month | 4.37 | 0.23 | 10.44 | (9.00) | 30.21 | |
| LMAT | LeMaitre Vascular | 0.55 | 8 per month | 1.30 | 0.09 | 3.12 | (2.19) | 9.47 | |
| ANGO | AngioDynamics | 0.02 | 13 per month | 0.00 | (0.05) | 3.71 | (4.03) | 18.73 | |
| ATRC | AtriCure | 0.19 | 9 per month | 1.37 | 0.14 | 4.67 | (3.12) | 23.09 | |
| AKYA | Akoya Biosciences | 0.03 | 7 per month | 0.00 | (0.04) | 8.59 | (4.96) | 40.94 | |
| ATR | AptarGroup | 0.48 | 10 per month | 0.88 | 0.07 | 1.47 | (1.37) | 7.86 | |
| ICUI | ICU Medical | (18.49) | 10 per month | 1.74 | (0.07) | 2.77 | (2.50) | 10.44 | |
| MMSI | Merit Medical Systems | 0.25 | 9 per month | 0.86 | (0.01) | 2.07 | (1.23) | 6.42 |
Utah Medical Additional Predictive Modules
Most predictive techniques to examine Utah price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Utah using various technical indicators. When you analyze Utah charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Utah Medical Predictive Indicators
The successful prediction of Utah Medical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Utah Medical Products, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Utah Medical based on analysis of Utah Medical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Utah Medical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Utah Medical's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0314 | 0.008651 | 0.014 | 0.0243 | Price To Sales Ratio | 7.43 | 6.99 | 6.1 | 3.45 |
Story Coverage note for Utah Medical
The number of cover stories for Utah Medical depends on current market conditions and Utah Medical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Utah Medical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Utah Medical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Utah Medical Short Properties
Utah Medical's future price predictability will typically decrease when Utah Medical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Utah Medical Products often depends not only on the future outlook of the potential Utah Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Utah Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.6 M | |
| Cash And Short Term Investments | 92.9 M |
Complementary Tools for Utah Stock analysis
When running Utah Medical's price analysis, check to measure Utah Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Utah Medical is operating at the current time. Most of Utah Medical's value examination focuses on studying past and present price action to predict the probability of Utah Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Utah Medical's price. Additionally, you may evaluate how the addition of Utah Medical to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |